Opioid Misuse
Conditions
Brief summary
The proposed study aims to develop and implement a text message intervention that will instruct and motivate individuals to securely store opioid medications during treatment and subsequently dispose of unused medications following treatment. It is relevant to public health as it is expected to meet the critical need of reducing the diversion of prescription opioids for nonmedical use. The proposed research is relevant to National Institute on Drug Abuse's priorities to develop and implement theoretically based, prevention interventions that can be scalable in healthcare settings to elicit population-level impacts to address the opioid crisis.
Detailed description
Drug overdoses are now the leading cause of injury-related death in the United States (US), 35% of which are due to nonmedical use of a prescribed opioid. In the US, 3.3 million people aged 12 or older report past 30-day nonmedical prescription opioid use (NMPOU), defined as use of a prescribed opioid analgesic without a prescription or for reasons other than prescribed. The existing supply of opioid analgesics is high; the prescribing rate equates to at least one opioid prescription per resident in the highest prescribing counties. Many of these opioid analgesics are leftover following treatment and kept in homes rather than being disposed after ceasing use or expiration. Over half of individuals who report NMPOU obtain prescription medications from a relative or friend, with or without their knowledge. Thus, diversion of excess medication is the primary source of NMPOU. Secure storage and disposal of unused opioid analgesics has been extensively promoted at the federal level and adopted by local communities as a strategy to combat diversion of NMPOU. The premise underlying these two strategies is that (1) secure storage minimizes the likelihood of diversion while opioid analgesics are being used during treatment and (2) disposal programs provide opportunities for patients to remove unused or expired opioids outside the home, ultimately reducing availability for NMPOU. However, recent evidence demonstrates that a majority of individuals do not securely store opioids analgesics and only a fraction of unused prescription opioids are disposed of through these take-back events and dropboxes. This is likely due, in part, to a widespread failure of knowledge about and lack of motivation to securely storing and disposing unused prescription opioids. There is evidence that increasing awareness of storage procedures and disposal mechanisms and targeted interventions delivered by healthcare systems may enhance secure storage and disposal of opioid medications. Mobile phone text message reminders, a technology used to prompt multiple health behaviors, may address the need to provide timely guidance on proper handling of opioid medications by prompting patients to securely store and dispose unused prescription opioids.
Interventions
The intervention consists of a series of text messages aimed to facilitate secure storage and disposal of unused opioid medications.
Information provided by the physician and/or pharmacist.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 years or older * able to read and speak English * owning a cell phone with the capability of receiving short message service (SMS) text messages * receiving an opioid prescription within the past 14 days
Exclusion criteria
* 17 years or younger * not able to read and speak English * does not own a cell phone with the capability of receiving SMS text messages * has not received an opioid prescription within the past 14 days
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Participants Who Securely Stored Their Opioid Medication During Treatment | 45 days following enrollment | Investigators will assess the differences in the percentage of participants who securely stored their opioid medication during treatment using a dichotomous, close-ended question on a self-administered questionnaire. |
| Percentage of Participants Who Disposed of Their Unused Opioid Medication | 45 days following enrollment | Investigators will assess the differences in the percentage of participants who disposed of their unused opioid medication following completion of treatment using a dichotomous, close-ended question on a self-administered questionnaire. |
Countries
United States
Contacts
Wake Forest University Health Sciences
Participant flow
Recruitment details
We used a multimethod approach to recruitment. Potential participants who were recently prescribed opioid medication were identified through Electronic Health Records (EHR) and sent a single message in their MyChart inviting them to participate. We also posted flyers in local pharmacies with study information. Participants were directed to an online consent form programmed in REDCap®. If the participant consented to participate, they completed the self-directed web-based eligibility screener.
Pre-assignment details
If eligible, they transitioned immediately from the screening questions to the baseline survey. Following completion of the baseline survey, the participant was randomized to study condition using simple randomization procedures with stratification by biological sex.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Customized 18-25 years | 24 Participants |
| Age, Customized 26-35 years | 71 Participants |
| Age, Customized 36-45 years | 81 Participants |
| Age, Customized 45-55 years | 97 Participants |
| Age, Customized 56-65 years | 63 Participants |
| Age, Customized 66-75 years | 40 Participants |
| Age, Customized 76+ years | 22 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 7 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 198 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 4 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 2 Participants |
| Race (NIH/OMB) Asian | 4 Participants |
| Race (NIH/OMB) Black or African American | 25 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 9 Participants |
| Race (NIH/OMB) White | 317 Participants |
| Sex: Female, Male Female | 134 Participants |
| Sex: Female, Male Male | 70 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 188 | 0 / 210 |
| other Total, other adverse events | 0 / 188 | 0 / 210 |
| serious Total, serious adverse events | 0 / 188 | 0 / 210 |